Categories: NewsPharmaceutical

BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Oili Halonen

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 8 December 2023 at 3.30 p.m. (EET)

BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Oili Halonen

____________________________________________

Person subject to the notification requirement
Name: Halonen Oili
Position: Closely associated person
(1):Person Discharging Managerial Responsibilities In Issuer
Name: Halonen Jarmo
Position: Member of the Board
Issuer: BBS Bioactive Bone Substitutes Oyj
LEI: 743700BYSBP0PCR6N767
Notification type: INITIAL NOTIFICATION
Reference number: 743700BYSBP0PCR6N767_20231208124156_4

____________________________________________

Transaction date: 2023-12-07
Venue not applicable
Instrument type: SHARE
ISIN: FI4000260583
Nature of the transaction: SUBSCRIPTION

Transaction details
(1): Volume: 2,475 Unit price: 0.4 EUR

Aggregated transactions
(1): Volume: 2,475 Volume weighted average price: 0.4 EUR

For more information, please contact:

Juliusz Rakowski, CEO
+358 50 448 5132
juliusz.rakowski@bbs-artebone.fi

Certified Advisor:
Nordic Certified Adviser AB,
+46 70 551 67 29,
info@certifiedadviser.se

BBS in brief

BBS -Bioactive Bone Substitutes Plc is a orthobiology company that started its operations in 2003. We have developed a new product for the treatment of complex bone fractures and bone healing issues. Our goal is to provide next-generation medical products for the treatment of bone injuries in orthopedic surgery. In the pharmaceutical industry, the development and research work require perseverance and courage to innovate. We have a track record of over 20 years in this field. Our company is characterized by expertise, innovation, and dedicated employees who are passionate about their work. Our first developed product, ARTEBONE® Paste, is in the final stages of the CE marking process to enable its commercialization in the EU market. We are based in Oulu with a medical manufacturing facility in Reisjärvi, holding a manufacturing license. The company’s headquarters are in Oulu, and we employ over 20 people.

BBS has been listed on Nasdaq First North Growth Market Finland since February 2018.

More information: www.bbs-artebone.fi

Staff

Recent Posts

As Sober.Buzz Community Explodes Its Growth Globally it is Announcing “Spreading the Good BUZZ” Podcast Hosted by Josh Case Debuting July 7th

Sober.Buzz's Online Store that includes the Exclusive Inspirational Collection by Heidi Case has Launched. Additionally,…

4 hours ago

STUDENTS STEP INTO THE ROLE OF ATHLETIC TRAINERS, CARDIOLOGISTS, DIETITIANS, AND MORE WITH FREE SUMMER SCIENCE PROGRAM!

GSK Science in the Summer™ Unveils New 2025 Theme: Be A Health Scientist! PHILADELPHIA, June…

4 hours ago

Healthy Interactions Expands Primary Care Alliance to Improve Cardiometabolic Care

JACKSON HOLE, Wyo., June 18, 2025 /PRNewswire/ -- Healthy Interactions LLC, a global leader in…

4 hours ago

RevelAi Health Secures $3.1 Million Seed Funding to Scale Artificial Intelligence Care Coordination for Musculoskeletal Health

DURHAM, N.C., June 18, 2025 /PRNewswire/ -- RevelAi Health, a conversational artificial intelligence (AI) platform…

4 hours ago

Atlanta Hair Transplant and Restoration Specialist Dr. Benjamin Stong Now Accepting Bitcoin (BTC) for Hair Transplant Procedures at KalosHairTransplant.com

Dr. Benjamin Stong, founder of Kalos Hair Transplant in Atlanta, is now accepting Bitcoin (BTC)…

4 hours ago